BIOLASE Inc (NASDAQ: BIOL) stated net revenue of $8.6M for the 3rd quarter, 2019
On Yesterday, BIOLASE Inc (NASDAQ: BIOL) has actually revealed increased move of 8.75% and ended the last trade at $0.87.
Read more
Healthcare Updates
Arcadia Biosciences Inc (NASDAQ: RKDA) delivered 3rd quarter business highlights
On Wednesday Arcadia Biosciences Inc (NASDAQ: RKDA) below -2.3% and ended at $5.1. The stock exchange capitalization got to $46.31
Read more
Arca Biopharma Inc (NASDAQ: ABIO) moved -3.7% downward recently
The stock rate is going above to its 52 week low with 17.18% and lagging behind from its 52 week
Read more
Aimmune Therapeutics Inc (NASDAQ: AIMT) provided finalized data highlights
Aimmune Therapeutics Inc (NASDAQ: AIMT), just recently reported financial results for the quarter and nine months ended September 30, 2019.
Read more
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) stated cash, cash equivalents and marketable securities value of $64.7M
On Thursday Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) listed below -1.9% and ended at $7.76. The stock exchange capitalization came
Read more
Analytical position of AngioDynamics, Inc. (NASDAQ: ANGO) as shown in quarterly report
U.S. net sales in the very first quarter of fiscal 2020 were $52.9 M, a raise of 2.8% from $51.5
Read more
Recent 4th fiscal quarter of Applied Genetic Technologies Corporation (NASDAQ: AGTC)
On The Other Day, Applied Genetic Technologies Corporation (NASDAQ: AGTC) has actually shown increased relocation of 2.56% and ended the
Read more
Natural Alternatives International, Inc. (NASDAQ: NAII) updated fiscal Q4 revenue results
On Friday, Natural Alternatives International, Inc. (NASDAQ: NAII) shares price traded between $7.78 and $8.13 during the last trading session
Read more
IsoRay, Inc. (NYSE: ISR) 4th quarterly revenue grew up 20%
Overall business expenses in the fourth quarter decreased 28% to $2.02 M contrast to $2.81 M in the previous year
Read more